ReviewPediatric pulmonology2026
A Narrative Review of Gene-Environment Interactions in Pediatric Pulmonology.
Review in Pediatric pulmonology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Does use of acetaminophen and/or NSAIDs increase the risk of developing bronchopulmonary dysplasia?Pediatric research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Genetic and environmental factors are known to shape the onset, course, and outcomes of pediatric lung disease, yet interactions between these variables are rarely considered in clinical practice. Gene-environment (GxE) interactions occur when the combined effect of a genetic variant and an environmental exposure differs from what would be expected from combining the effect of either variable alone. Considering these interactions may reveal subgroups at heightened risk, explain apparent inconsistencies across studies, and highlight opportunities for targeted intervention. In this narrative review, we outline the conceptual basis of GxE interactions, including the importance of scale, centering, and timing. We summarize their implications and provide a high-level overview of available analytic strategies. We then examine disease-specific findings in asthma, cystic fibrosis, and bronchopulmonary dysplasia, highlighting how GxE processes can shape lung health from early life into adulthood and may contribute to chronic obstructive pulmonary disease risk. Across the asthma and cystic fibrosis examples presented here, commonly reported interactions involve genes related to host defense and oxidative stress biology, with effects that appear sensitive to exposure timing and developmental context. We conclude by identifying near-term priorities for improving rigor, mechanistic integration, and translation. Together, these insights frame pediatric lung disease within a life-course GxE model, emphasizing that genetic susceptibility and environmental risk should be considered jointly to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.